期刊
ELIFE
卷 12, 期 -, 页码 -出版社
eLIFE SCIENCES PUBL LTD
DOI: 10.7554/eLife.91831
关键词
doxorubicin; cardiotoxicity; EPAC1; cancer survivorship; Human; Mouse; Rat
类别
Blocking protein EPAC1 can potentially halt the progression of chemotherapy-induced heart-related side effects.
Blocking a protein known as EPAC1 may prevent the development of heart-related side effects caused by a chemotherapy drug.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据